4926 - 4950 of 5662 Results
Title
Year
- Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons2014OPENTitle: Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 69Issue #:Start Page: 263End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.05.012Best OA location URL: https://escholarship.org/content/qt1671v5hw/qt1671v5hw.pdf?t=rsszc6Citation Count: 31
-
OPENTitle: Peptidoglycan recognition protein genes and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1171End Page: 1180Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25895Best OA location URL: https://europepmc.org/articles/pmc4777298?pdf=renderCitation Count: 46
- The timing and amount of vagus nerve stimulation during rehabilitative training affect poststroke recovery of forelimb strength2014OPENTitle: The timing and amount of vagus nerve stimulation during rehabilitative training affect poststroke recovery of forelimb strengthJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 25Issue #: 9Start Page: 676End Page: 682Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0000000000000154Best OA location URL: https://europepmc.org/articles/pmc4039714?pdf=renderCitation Count: 99
-
OPENTitle: Initial cognitive decline is associated with cortical thinning in early Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 22Start Page: 2017End Page: 2025Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000483Best OA location URL: https://europepmc.org/articles/pmc4105257?pdf=renderCitation Count: 176
- Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease2014OPENTitle: Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 5Start Page: e97032End Page: e97032Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0097032Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0097032&type=printableCitation Count: 68
- Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days2014OPENTitle: Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 DaysJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 5Start Page: e96675End Page: e96675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0096675Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096675&type=printableCitation Count: 197
-
OPENTitle: In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriersJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1197End Page: 1201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25893Best OA location URL: https://europepmc.org/articles/pmc4139463?pdf=renderCitation Count: 16
- Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology2014OPENTitle: Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of PathologyJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 5Start Page: e94839End Page: e94839Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0094839Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094839&type=printableCitation Count: 353
-
OPENTitle: Sequential Voluntary Cough and Aspiration or Aspiration Risk in Parkinson’s DiseaseJournal Name: LungPublisher: Springer Science and Business Media LLCVol: 192Issue #: 4Start Page: 601End Page: 608Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00408-014-9584-7Best OA location URL: https://europepmc.org/articles/pmc4740922?pdf=renderCitation Count: 82
- Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s disease2014OPENTitle: Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1563Issue #:Start Page: 103End Page: 109Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2014.03.031Best OA location URL: https://europepmc.org/articles/pmc4146456?pdf=renderCitation Count: 15
- Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects2014OPENTitle: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 571Issue #:Start Page: 34End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027Best OA location URL: https://europepmc.org/articles/pmc4591751?pdf=renderCitation Count: 120
-
OPENTitle: High-throughput neuroimaging-genetics computational infrastructureJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2014.00041Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2014.00041/pdfCitation Count: 29
- Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotes2014OPENTitle: Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 6Start Page: 752End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.313Best OA location URL: https://europepmc.org/articles/pmc4082726?pdf=renderCitation Count: 182
- Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP12014OPENTitle: Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 18Start Page: 6804End Page: 6809Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1321845111Best OA location URL: https://www.pnas.org/content/pnas/111/18/6804.full.pdfCitation Count: 189
- Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment From Across the Adult Life Span2014OPENTitle: Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment From Across the Adult Life SpanJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 6Start Page: 742End Page: 742Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.445Best OA location URL: https://europepmc.org/articles/pmc4051849?pdf=renderCitation Count: 39
-
OPENTitle: MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms4633Best OA location URL: https://www.nature.com/articles/ncomms4633.pdfCitation Count: 282
-
OPENTitle: Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 17Start Page: 4621End Page: 4638Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddu178Best OA location URL: https://academic.oup.com/hmg/article-pdf/23/17/4621/2215861/ddu178.pdfCitation Count: 142
- Positive Reinforcement Mediated by Midbrain Dopamine Neurons Requires D1 and D2 Receptor Activation in the Nucleus Accumbens2014OPENTitle: Positive Reinforcement Mediated by Midbrain Dopamine Neurons Requires D1 and D2 Receptor Activation in the Nucleus AccumbensJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 4Start Page: e94771End Page: e94771Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0094771Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094771&type=printableCitation Count: 140
- Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice2014OPENTitle: Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic MiceJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 4Start Page: e94826End Page: e94826Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0094826Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094826&type=printableCitation Count: 29
- The Thorny Problem of Dyskinesias: Dendritic Spines, Synaptic Plasticity, and Striatal Dysfunction2014OPENTitle: The Thorny Problem of Dyskinesias: Dendritic Spines, Synaptic Plasticity, and Striatal DysfunctionJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 75Issue #: 9Start Page: 676End Page: 677Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2014.02.019Best OA location URL: https://europepmc.org/articles/pmc4120525?pdf=renderCitation Count: 1
-
OPENTitle: Essential Tremor in the Elderly and Risk for DementiaJournal Name: Journal of Neurodegenerative DiseasesPublisher: Hindawi LimitedVol: 2014Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/328765Best OA location URL: https://downloads.hindawi.com/archive/2014/328765.pdfCitation Count: 22
-
OPENTitle: Evaluation of mild cognitive impairment subtypes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 756End Page: 764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25875Best OA location URL: https://europepmc.org/articles/pmc4013249?pdf=renderCitation Count: 55
- Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits2014OPENTitle: Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficitsJournal Name: Frontiers in Systems NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsys.2014.00045Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnsys.2014.00045/pdfCitation Count: 96
- Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease2014OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: https://europepmc.org/articles/pmc4892899?pdf=renderCitation Count: 63
- Can Isolated Enlarged Virchow-Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?2014OPENTitle: Can Isolated Enlarged Virchow-Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 1Start Page: 67End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12009Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12009Citation Count: 15